Drug Promotion - What We Know, What We Have Yet to Learn - Reviews of Materials in the WHO/HAI Database on Drug Promotion - EDM Research Series No. 032
(2004; 102 pages) View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentExecutive summary
Open this folder and view contentsIntroduction
Open this folder and view contentsReview 1. What attitudes do professional and lay people have to promotion?
Open this folder and view contentsReview 2. What impact does pharmaceutical promotion have on attitudes and knowledge?
Open this folder and view contentsReview 3. What impact does pharmaceutical promotion have on behaviour?
Close this folderReview 4. What interventions have been tried to counter promotional activities, and with what results?
View the document4.1 Guidelines, codes and regulations for printed and broadcast material
View the document4.2. The ‘Fair Balance’ requirement
View the document4.3 Guidelines for sales representatives
View the document4.4 Guidelines for post-marketing surveillance
View the document4.5 Guidelines on conflict of interest in research
View the document4.6 Guidelines for package inserts and compendia
View the document4.7 Guidelines about gifts
View the document4.8 Guidelines for trainee doctors and for hospitals
View the document4.9 Knowledge of these guidelines and their effect on attitudes
View the document4.10 Education about promotion
View the document4.11 Monitoring/countering promotion
View the document4.12 Research as an intervention
View the documentSummary of conclusions
View the documentDirections for future research
View the documentFinal conclusions
View the documentReferences
 

4.9 Knowledge of these guidelines and their effect on attitudes

Only 23% of family medicine registrars surveyed by Sergeant et al.5 had read the Canadian Medical Association’s (CMA) guidelines on appropriate interactions between doctors and representatives. Although six of the seven training centres had policies or referred to guidelines, only 26% of residents thought that their institution did. Although accepting a private dinner provided by a company contravenes the CMA guidelines, residents who knew about the guidelines, or were aware that their training centre had a policy about this, were no less likely to say they would accept such a dinner. However at one centre where company-sponsored lunches were not allowed, and where there was a teaching session on interacting with industry representatives, residents were less likely to see the literature from sales representatives as useful, and were less likely to say they would accept the private dinner or see representatives when they were practicing.

Brotzman and Mark232 also looked at whether residency programmes’ policies on drug sales representatives affected the attitudes of residents in the programmes. They randomly selected 14 US family medicine residency programmes, of which seven had written policies and at least one restriction on the activities of sales representatives. Residents in programmes with no policy were four times as likely to see detailing as a helpful source of information, and twice as likely to see journal advertisements as helpful, as residents in programmes with policies (the latter difference was not statistically significant). Those in programmes without policies felt gifts were more acceptable, and had more interactions with sales representatives. Brotzman and Mark note several possible reasons for this association between policies and residents’ attitudes. Residents may interpret the absence of a policy as approval by the programme directors of promotional activities; programmes may differ in their culture regarding promotion; residents in programmes without policies may be exposed to more promotion, be more used to it and therefore more accepting. In addition programmes with policies may also include other interventions which shape residents’ attitudes. However, when Brotzman and Mark removed from the analysis the three programmes with an explicit curriculum in this area, the results remained the same.

Ferguson et al.233 asked practicing internists (internal medicine specialists) in the US whether they had trained in an institution with an enforced policy about sales representatives, and whether they now saw sales representatives and accepted samples. They found no differences in whether doctors now saw sales representatives and accepted samples between those who had trained in an institution with an enforced policy and others. This suggests that any impact of policies during training may not persist over time.

McCormick et al.234 reached different conclusions. They compared doctors who had trained at a Canadian medical school which did not have a policy restricting sales representatives’ access to residents, with those who trained at another medical school which did have such a policy. They also compared doctors who had trained at the second school before the policy had been introduced. Those who trained while the policy was in force were less likely to find information from sales representatives beneficial in guiding their practice than other doctors several years after they graduated. The authors speculate that this could be due to the educational environment, to strong faculty opinions, or the doctors never having learnt to interact in a constructive way with sales representatives.

CONCLUSION: There is conflicting evidence about whether guidelines affect the attitudes of trainee doctors and if so whether any effects persist over time. Guidelines alone seem to have no strong influence on the attitudes of trainee doctors, but can be effective together with active faculty support in an academic setting.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014